Literature DB >> 6233388

The murine lymphocyte receptor for IgE. II. Characterization of the multivalent nature of the B lymphocyte receptor for IgE.

W T Lee, D H Conrad.   

Abstract

The murine B lymphocyte Fc epsilon R is functionally multivalent. Radiolabeled rat IgE, when bound to the B cell Fc epsilon R will co-isolate with the Fc epsilon R on a rat IgE affinity column; examination of the affinity column eluate by SDS-PAGE reveals the component previously identified as the Fc epsilon R as well as E and L chains from IgE. At low levels of Fc epsilon R saturation, up to 30% of the Fc epsilon R bound IgE becomes bound to IgE-Affi-Gel. By using a biotin-avidin system, the coprecipitation of non-haptenated IgE with haptenated IgE was examined and the results suggest (but do not prove) a divalent receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233388      PMCID: PMC2187318          DOI: 10.1084/jem.159.6.1790

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Characterization of an IgE receptor isolated from cultured B-type lymphoblastoid cells.

Authors:  G C Meinke; A M Magro; D A Lawrence; H L Spiegelberg
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  Characterization of the target cell receptor for IgE. III. properties of the receptor isolated from rat basophilic leukemia cells by affinity chromatography.

Authors:  D H Conrad; A Froese
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

Review 3.  Lymphocytes bearing Fc receptors for IgE.

Authors:  H L Spiegelberg
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  Fc receptors specific for IgE on subpopulations of human lymphocytes and monocytes.

Authors:  H L Spiegelberg; F M Melewicz
Journal:  Clin Immunol Immunopathol       Date:  1980-03

5.  Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding.

Authors:  S K Dower; C DeLisi; J A Titus; D M Segal
Journal:  Biochemistry       Date:  1981-10-27       Impact factor: 3.162

6.  Characterization of the target cell receptor for IgE. II. Polyacrylamide gel analysis of the surface IgE receptor from normal rat mast cells and from rat basophilic leukemia cells.

Authors:  D H Conrad; A Froese
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

7.  A subpopulation of normal human peripheral B lymphcytes that bind IgE.

Authors:  A Gonzalez-Molina; H L Spiegelberg
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

8.  Binding parameters of the interaction between rat IgE and rat mast cell receptors.

Authors:  D H Conrad; H Bazin; A H Sehon; A Froese
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

9.  Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes.

Authors:  R Vander-Mallie; T Ishizaka; K Ishizaka
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

10.  The murine lymphocyte receptor for IgE. I. Isolation and characterization of the murine B cell Fc epsilon receptor and comparison with Fc epsilon receptors from rat and human.

Authors:  D H Conrad; L H Peterson
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

View more
  3 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 2.  Low affinity IgE receptors (Fc epsilon RII).

Authors:  D H Conrad
Journal:  Clin Rev Allergy       Date:  1989

3.  CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution.

Authors:  R L Beavil; P Graber; N Aubonney; J Y Bonnefoy; H J Gould
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.